Uncovering the spread of deadly cancer

August 26, 2011
A first-of-a-kind look at the brain cancer, glioblastoma multiforme, was obtained using a new imaging technique at Case Western Reserve University School of Medicine. The main tumor is green, blood vessels feeding the tumor are red and migrating cells, yellow. Credit: Case Western Reserve University School of Medicine

For the first time, scientists can see pathways to stop a deadly brain cancer in its tracks. Researchers at Case Western Reserve University School of Medicine have imaged individual cancer cells and the routes they travel as the tumor spreads.

The researchers used a novel cryo-imaging technique to obtain the unprecedented look at a mouse model of , a particularly that has no treatments to stop it from spreading.

A description of their work, and images, will be published Sept. 1 in the journal Cancer Research.

"We're able to see things we couldn't before, and we can use these images to understand how invade and disperse," said Susann M. Brady-Kalnay, a professor of molecular biology and microbiology at the Case Western Reserve School of Medicine, and senior author of the paper.

That information, in turn, can be used to help develop and test the effectiveness of drugs and other therapies used to treat the cancer, she said.

To obtain the view, the scientists used a model that included four different cell lines of brain cancers at various stages of and dispersion. The were modified with fluorescent markers and implanted in the model's brain in collaboration with Biomedical Engineering Professor James Basilion's lab.

The cryo-imaging system, developed by David Wilson, also a professor of biomedical engineering at Case Western Reserve, disassembles the brain layer by layer and reassembles the model into a color three-dimensional digital image.

Using software and algorithms designed by the researchers, they are able to differentiate the main tumor mass, the blood vessels that feed the cancer and dispersing cells. The imaging system enables them to peer at single cells and see exactly where they are in the brain.

The lead researchers, Susan Burden-Gulley, Mohammed Qutaish and Kristin Sullivant, found that two cell lines, a human LN229, and a rodent cancer CNS-1, best resemble the actions of glioblastoma multiforme in human patients.

Reconstructions of models of those two lines enabled the researchers to analyze the extent and patterns of cancer cell migration and dispersal from tumors along blood vessels and white matter tracts within the brain.

The ability to produce such clear and detailed images, the researchers say, will be invaluable when evaluating the potency of drugs and other therapies designed to block dispersal of glioblastoma multiforme cells.

Related Stories

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.